Gene · 2254
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine. | Clin Transl Sci | 2023 | 38062923 | PubTator, text mining | PubMed |
| Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma. | BMC Cancer | 2023 | 38062443 | PubTator, text mining | PubMed |
| Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition. | NPJ Precis Oncol | 2023 | 38062117 | PubTator, text mining | PubMed |
Synthesis, Characterization, and Computational Studies on Gallium(III) and Iron(III) Complexes with a Pentadentate Macrocyclic bis-Phosphinate Chelator and Their Investigation As Molecular Scaffolds for 18F Binding. | Inorg Chem | 2023 | 38055373 | PubTator, text mining | PubMed |
| FGF-independent MEK1/2 signalling in the developing foetal testis is essential for male germline differentiation in mice. | BMC Biol | 2023 | 38053127 | PubTator, text mining | PubMed |
| Kidney tissue regeneration using bioactive scaffolds incorporated with differentiating extracellular vesicles and intermediate mesoderm cells. | Biomater Res | 2023 | 38049879 | PubTator, text mining | PubMed |
| Sex Reversal Syndrome (SRS): A Case of SRY-Positive 46,XX Testicular Disorder. | J ASEAN Fed Endocr Soc | 2023 | 38045677 | PubTator, text mining | PubMed |
| Role of PDGFRA+ cells and a CD55+ PDGFRALo fraction in the gastric mesenchymal niche. | Nat Commun | 2023 | 38042929 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. | Front Immunol | 2023 | 38022534 | PubTator, text mining | PubMed |
| Revealing the impact of TOX3 on osteoarthritis: insights from bioinformatics. | Front Med (Lausanne) | 2023 | 38020130 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Directed Reprogramming of iPSC for Accelerated Motor Neuron Differentiation Leads to Dysregulation of Neuronal Fate Patterning and Function. | Int J Mol Sci | 2023 | 38003351 | PubTator, text mining | PubMed |
| In Vivo Assessment of Laboratory-Grown Kidney Tissue Grafts. | Bioengineering (Basel) | 2023 | 38002385 | PubTator, text mining | PubMed |
| Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy. | Medicine (Baltimore) | 2023 | 37986381 | PubTator, text mining | PubMed |
| The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis. | J Ovarian Res | 2023 | 37986114 | PubTator, text mining | PubMed |
| HIF-1α promotes kidney organoid vascularization and applications in disease modeling. | Stem Cell Res Ther | 2023 | 37981699 | PubTator, text mining | PubMed |
| The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease. | Signal Transduct Target Ther | 2023 | 37980330 | PubTator, text mining | PubMed |
| Efficient protocol for the differentiation of kidney podocytes from induced pluripotent stem cells, involving the inhibition of mTOR. | Sci Rep | 2023 | 37973990 | PubTator, text mining | PubMed |
| Mesenchymal stromal/stem cells and bronchopulmonary dysplasia. | Front Cell Dev Biol | 2023 | 37965579 | PubTator, text mining | PubMed |
| Highly-parallel production of designer organoids by mosaic patterning of progenitors. | bioRxiv | 2023 | 37961546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2254/papers?page=10